Tian Yong, Huang Weigeng, Sheng Zhijia, Yan Dingyuan, Wang Dong, Tang Ben Zhong
Center for AIE Research, Guangdong Provincial Key Laboratory of New Energy Materials Service Safety, Shenzhen University, Shenzhen 518060, China.
College of Materials Science and Engineering, Shenzhen University, Shenzhen 518060, China.
Chem Biomed Imaging. 2025 Mar 4;3(6):341-351. doi: 10.1021/cbmi.4c00108. eCollection 2025 Jun 23.
Aggregation-induced emission luminogens (AIEgens) have been prosperously developed and applied in the fields of optical imaging and theranostics since its establishment. Nowadays, AIEgens can fulfill nearly all requirements in optical imaging and theranostics with emission spectra ranging from visible to near-infrared wavelengths. Although a variety of AIEgens with varying wavelengths and functionalities have been continuously designed, their performance is heavily dependent on the use of conventional light sources, such as xenon lamps and lasers, which severely hinder further applications due to limited penetration depth and background autofluorescence in biological tissues. To mitigate these limitations and maximize the potential of AIEgens, unconventional excitation sources such as chemical energy, ultrasound, and X-ray offer effective alternatives that circumvent the drawbacks associated with traditional light-based constant excitation. In this Review, we introduce the fundamental principles governing the combination of unconventional excitation sources with AIEgens, highlight recent advancements in using AIEgens excited by these unconventional sources for bioimaging and theranostics, and discuss current challenges and future perspectives aimed at advancing the biomedical applications of AIEgens.
聚集诱导发光发光体(AIEgens)自问世以来得到了蓬勃发展,并应用于光学成像和诊疗领域。如今,AIEgens能满足光学成像和诊疗领域几乎所有的要求,其发射光谱范围从可见光到近红外波长。尽管不断设计出了各种具有不同波长和功能的AIEgens,但其性能在很大程度上依赖于传统光源的使用,如氙灯和激光,由于生物组织中穿透深度有限和背景自发荧光,这严重阻碍了其进一步应用。为了减轻这些限制并最大限度地发挥AIEgens的潜力,化学能、超声和X射线等非常规激发源提供了有效的替代方案,规避了与传统基于光的恒定激发相关的缺点。在本综述中,我们介绍了非常规激发源与AIEgens结合的基本原理,突出了利用这些非常规源激发的AIEgens进行生物成像和诊疗的最新进展,并讨论了推进AIEgens生物医学应用目前面临的挑战和未来前景。